Takeda Pharmaceutical (TAK) FCF Payout Ratio (2018 - 2026)

Takeda Pharmaceutical's FCF Payout Ratio history runs 9 years deep, the most recent figure standing at 10.5 for Q1 2026.

• On a quarterly basis, FCF Payout Ratio fell 130.26% year-over-year to 10.5 in Q1 2026; TTM through Mar 2026 was 0.27, a 23.66% decrease from a year earlier, with the FY2026 full-year figure at 0.3, down 15.12% from the prior year.
• FCF Payout Ratio fell to 10.5 in Q1 2026 per TAK's latest filing, from 0.36 in the prior quarter.
• Across five years, FCF Payout Ratio topped out at 11.37 in Q1 2023 and bottomed at 20.42 in Q1 2024.
• The 5-year median for FCF Payout Ratio is 0.36 (2025), against an average of 1.51.
• Across the five-year window, FCF Payout Ratio soared 235.87% in 2023 and sank 279.6% in 2024, its largest moves.
• Year by year, FCF Payout Ratio stood at 0.31 in 2022, then plunged by 128.0% to 0.71 in 2023, then surged by 52.52% to 0.34 in 2024, then fell by 5.91% to 0.36 in 2025, then slumped by 2824.0% to 10.5 in 2026.
• Per Business Quant, the three latest TAK FCF Payout Ratio figures stand at 10.5 (Q1 2026), 0.36 (Q4 2025), and 0.02 (Q3 2025).